Mental Health

BrainsWay Receives FDA Clearance for Accelerated Deep TMS Protocol for Non-Invasive Treatment of Major Depressive Disorder (MDD)

Clinical data shows that BrainsWay’s new accelerated stimulation protocol is comparable to standard Deep TMS in depression score improvement, response...

Reunion Neuroscience Announces Final Closing of its Series A Financing and Plans to Advance RE104 into Clinical Development for the Treatment of Generalized Anxiety Disorder (GAD)

Bow River Capital’s Software Growth Equity Team Completes Majority Recapitalization of meQuilibrium with RippleWorx. The Merger Creates the Market-Leading Human Capital Management Firm Addressing Workforce Mental Health and Performance Risks

Medical Care Technologies Inc. (OTC Pink:MDCE) Subsidiary Infinite Auctions Secures $2.54M Memorabilia Inventory, Reinforcing Growth and Supporting AI Healthcare Mission

Hazelden Betty Ford and Sigma Chi Launch Partnership to Expand Access and Inspire a New Standard for Behavioral Health Support

Initiative reduces stigma, streamlines access to care, and provides financial support; offering a model for other organizations nationwide.Center City, Minnesota--(Newsfile...

A Landmark Pivotal Study Applying Precision Medicine to Psychiatry with Denovo’s DB104 (liafensine) for Treatment-Resistant Depression Published in JAMA Psychiatry

The study represents the first successful prospective genetic biomarker-guided drug trial in psychiatrySAN DIEGO, Sept. 11, 2025 (GLOBE NEWSWIRE) --...

Health-E Commerce® and Biotricity® Collaborate to Expand Remote Cardiac Monitoring with Bioheart® for Flexible Spending Account (FSA) and Health Savings Account (HSA) Users

Health-E Commerce® and Biotricity® Collaborate to Expand Remote Cardiac Monitoring with Bioheart® for Flexible Spending Account (FSA) and Health Savings Account (HSA) Users

error: Content is protected !!